CNBX Pharmaceuticals Inc. Financial Ratios — CNBX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	08/31/2022	08/31/2023	08/31/2024	08/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	-135.26	13.03	-90.47	-178.94	- -	- -	- -	- -
Return on Assets (%)	-226.01	- -	-155.04	-288.81	-757.58	-1,172	-105.63	-110.71	12.34	-85.82	-120.58	-225.82	-566.36	-262.13	-1,260.44
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	13.24	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-37.99	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	100	100	100	100	100	- -	100	100	100	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	-248.09	-32,492.59	-38,748.96	-31,643.59	-39,517.9	- -	-9,197.69	-187.56	-392.71	- -
Operating Margin (%)	- -	- -	- -	- -	- -	-249.49	-32,616.08	-39,670.12	-33,563.01	-42,524.12	- -	-9,860.37	-227.07	-448.31	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-6,193.57	- -	- -	- -	-239.44
Pretax Margin (%)	- -	- -	- -	- -	- -	-273.05	-34,022.54	-39,335.66	11,510.4	-104,337.89	- -	-14,661.8	-904.57	-534.46	- -
Profit Margin (%)	- -	- -	- -	- -	- -	-273.05	-34,022.54	-39,335.66	11,510.41	-104,337.91	- -	-14,661.8	-904.57	-534.46	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-273.05	-34,022.54	-39,335.66	11,510.41	-104,337.91	- -	-14,661.8	-904.57	-534.46	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	-135.26	13.03	-90.47	-178.94	- -	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	08/31/2022	08/31/2023	08/31/2024	08/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	1	1	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	1	1	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.37	-0.64	-1.75	-2.54	-4.41
Net Debt/EBITDA	- -	- -	1.26	0.46	0.05	0.07	1.82	0.37	0.09	0.27	0.22	-0.6	-1.58	-2.48	-4.35
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.34	-0.6	-1.44	-2.22	-4.41
Net Debt/EBIT	- -	- -	1.26	0.46	0.05	0.07	1.82	0.37	0.08	0.26	0.2	-0.56	-1.3	-2.18	-4.35
EBITDA to Interest Expense	- -	-1,568.38	-323.64	-221.5	-176.87	-10.27	-422.34	- -	-169.76	-347.71	-995.09	-2,164.53	-655.3	-26.05	-6.76
EBITDA-CapEx/Interest Expense	- -	-1,568.38	-323.64	-253.99	-177.87	-10.27	-451.1	- -	-181.58	-357.03	-995.48	-2,165.83	-655.3	-26.11	-6.76
EBIT to Interest Expense	- -	-1,568.38	-323.64	-221.59	-177.3	-10.33	-423.94	- -	-180.05	-374.16	-1,087.49	-2,320.48	-793.34	-29.74	-6.76
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	- -	- -	-144.86	35.09	-1,078.69	-1,971.03	80.78	83.06	97.11	79.51	58.65	-201.23	-404.23	-7,902.3	-13,539.58
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.28	-107.74	-66.6	-52.22	-47.96
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.56	1,391.48	-199.43	-109.3	-92.17
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.32	216.81	269.23	4,126.78	6,493.77
Net Debt to Equity	- -	- -	69.03	-246.41	8.15	4.09	-114.6	-52.68	-1.8	-44.07	-28.49	-100.54	-60.17	-51.16	-47.36
Net Debt/Capital (%)	- -	- -	40.84	168.3	7.53	3.93	784.9	-111.32	-1.84	-78.79	-39.85	18,490.16	-151.09	-104.74	-89.96
EBITDA	- -	- -	- -	- -	-1	- -	-2	-4	-3	-3	-2	-3	-1	-1	- -
EBITDA-CapEx	- -	- -	- -	- -	-1	- -	-2	-5	-3	-3	-2	-3	-1	-1	- -
Operating Income (Loss)	- -	- -	- -	- -	-1	- -	-2	-4	-3	-3	-3	-3	-1	-1	- -

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	08/31/2022	08/31/2023	08/31/2024	08/31/2025

Cash Ratio	- -	- -	0.41	1.33	0.07	0.04	4.82	2.58	8.03	1.71	1.09	0.05	0.05	0.01	0.01
Current Ratio	- -	- -	0.41	1.52	0.08	0.04	5.03	3.01	9.81	2.04	1.25	0.08	0.09	0.01	0.01
Quick Ratio	- -	- -	0.41	1.33	0.08	0.04	5.03	3.01	8.67	2.04	1.25	0.08	0.09	0.01	0.01
CFO/Avg Current Liab	- -	- -	-0.24	-1.55	-0.87	-0.29	-1.45	-3.19	-6.33	-6.21	-2.89	-0.9	-0.05	-0.1	-0.07
Common Equity/Total Assets	- -	- -	-144.86	35.09	-1,078.69	-1,971.03	80.78	83.06	97.11	79.51	58.65	-201.23	-404.23	-7,902.3	-13,539.58
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.28	-107.74	-66.6	-52.22	-47.96
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.56	1,391.48	-199.43	-109.3	-92.17
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.32	216.81	269.23	4,126.78	6,493.77
CFO/Total Liabilities	- -	- -	-15.29	-263.58	-52.92	-24.45	-123.52	-366.1	-704.94	-610.17	-195.82	-68.72	-4.47	-9.73	-6.81
CFO/CapEx	- -	- -	- -	-6.19	-58.9	- -	-6.87	-2.1	-14.26	-36.63	-2,643.6	-1,014	- -	-204.24	- -
Altman's Z-Score	- -	- -	-13.02	390.71	-104.75	-145.16	102.54	116.32	46.49	21.17	1.6	-49.72	-78.81	-1,265.17	-2,129.77

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	08/31/2022	08/31/2023	08/31/2024	08/31/2025

Accounts Receivable Turnover

- -

Days Sales Outstanding

- -

Inventory Turnover

- -

Days Inventory Outstanding

- -

Accounts Payable Turnover

- -

Accounts Payable Turnover Days

- -

Cash Conversion Cycle

- -

Inventory to Cash Days

- -

Inventories

- -

Raw Materials

- -

Work In Process

- -

Finished Goods

- -

Other Inventory

- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	08/31/2022	08/31/2023	08/31/2024	08/31/2025

Market Capitalization	- -	- -	- -	50	18	5	122	111	35	26	25	4	- -	- -	- -
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	3	1	- -	1	1	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	1	1	1
Enterprise Value	- -	- -	- -	50	18	5	119	109	31	25	25	6	2	1	1
Total Capital	- -	- -	- -	- -	- -	- -	3	3	15	2	3	- -	-1	-1	-1
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.56	1,391.48	-199.43	-109.3	-92.17
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.04	0.3	0.84	0.89	0.82
EV/Sales	- -	- -	- -	- -	- -	47.32	20,859.1	11,377.51	3,194.74	3,496.12	- -	197.55	3.89	11.24	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	13,080	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	13,080	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	50	18	5	113	110	34	26	24	4	- -	- -	- -
Diluted Enterprise Value	- -	- -	- -	50	18	5	109	108	34	25	23	6	1	1	1
EV per Share	29.4	15	2.58	59.87	21.57	5.96	119.02	107.82	28.06	22.23	19.98	4.7	0.07	0.05	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	- -	- -	- -	-1	- -	-2	-4	-3	-3	-2	-3	-1	-1	- -
TTM Operating Income	- -	- -	- -	- -	-1	- -	-2	-4	-3	-3	-3	-3	-1	-1	- -
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	-1	-2	-3	-3	-2	-2	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	-1	-1	-3	-3	-2	-2	- -	- -	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	08/31/2011	08/31/2012	08/31/2013	08/31/2014	08/31/2015	08/31/2016	08/31/2017	08/31/2018	08/31/2019	08/31/2020	08/31/2021	08/31/2022	08/31/2023	08/31/2024	08/31/2025

Price/Free Cash Flow	- -	- -	-3.74	-305.83	-102.98	-42.84	-152.6	-106.11	-11.97	-9.52	-9.45	-2.48	-1.33	-0.77	-0.26
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	50	18	5	119	109	31	25	25	6	2	1	1
Low Price	18	7.8	9	3.6	13.86	2.52	4.8	72	30	8.4	16.2	0.08	0.01	- -	- -
EV/Sales	- -	- -	- -	- -	- -	47.32	20,859.1	11,377.51	3,194.74	3,496.12	- -	197.55	3.89	11.24	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	30.39	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-5.99	-79.95	-2.24	-70.2	-46.01	-21.71	-69.32	-34.6	49.79	-4.23	-10.15	-2.31	-3.02	-0.55	-1.74
Price/Earnings High	-19.01	-201.74	-3.26	-519.78	-94.86	-60.5	-433.78	-95.3	157.82	-10.99	-26.02	-6.01	-11.42	-2.12	-5.75
Price/Earnings Low	-1.9	-53.52	-1.81	-11.14	-21.48	-7.06	-2.28	-19.12	29.23	-1.26	-5.85	-0.02	-0.02	-0.22	-0.09
Price/Book Value	-7.04	-3.47	-0.97	1,250.3	-59.01	-11.43	41.49	41.82	2.37	14.62	13.99	-2.62	-0.19	-0.08	-0.11
Price/Book Value Average	-13.59	-2.7	-1.2	472.86	-81.09	-14.81	49.41	49.89	3.88	17.97	19.27	-6.39	-14.23	-0.16	-1.34
Price/Book Value High	-43.1	-6.8	-1.74	3,501.43	-167.18	-41.29	309.16	137.4	12.31	46.7	49.39	-16.65	-53.8	-0.61	-4.42
Price/Book Value Low	-4.31	-1.8	-0.97	75.03	-37.86	-4.82	1.63	27.57	2.28	5.36	11.11	-0.06	-0.11	-0.06	-0.07
Price/Tangible Book Value	-7.04	-3.47	-0.97	1,250.3	-59.01	-11.43	41.49	41.82	3.21	14.62	13.99	-2.62	-0.19	-0.08	-0.11
Price/Tangible Book Value Average	-13.59	-2.7	-1.2	472.86	-81.09	-14.81	49.41	49.89	5.26	17.97	19.27	-6.39	-14.23	-0.16	-1.34
Price/Tangible Book Value High	-43.1	-6.8	-1.74	3,501.43	-167.18	-41.29	309.16	137.4	16.69	46.7	49.39	-16.65	-53.8	-0.61	-4.42
Price/Tangible Book Value Low	-4.31	-1.8	-0.97	75.03	-37.86	-4.82	1.63	27.57	3.09	5.36	11.11	-0.06	-0.11	-0.06	-0.07
Price/Sales	- -	- -	- -	- -	- -	45.74	19,807.07	11,409.15	3,498.51	3,590.66	- -	138.76	0.36	1.44	- -
Price/Sales Average	- -	- -	- -	- -	- -	59.28	23,585.56	13,610.81	5,730.63	4,414.21	- -	338.53	27.31	2.95	- -
Price/Sales High	- -	- -	- -	- -	- -	165.21	147,582.11	37,487.22	18,165.35	11,467.55	- -	881.54	103.27	11.32	- -
Price/Sales Low	- -	- -	- -	- -	- -	19.27	776.75	7,522.52	3,363.95	1,315.95	- -	3.06	0.21	1.16	- -
Price/Cash Flow	- -	- -	-3.74	-256.45	-101.23	-42.84	-130.37	-55.47	-11.13	-9.26	-9.45	-2.48	-1.33	-0.77	-0.26
Price/Cash Flow Average	- -	- -	-4.63	-96.99	-139.13	-55.53	-155.24	-66.18	-18.23	-11.38	-13.01	-6.04	-99.57	-1.57	-3.19
Price/Cash Flow High	- -	- -	-6.74	-718.18	-286.83	-154.75	-971.39	-182.26	-57.79	-29.58	-33.34	-15.73	-376.45	-6.03	-10.53
Price/Cash Flow Low	- -	- -	-3.74	-15.39	-64.96	-18.05	-5.11	-36.57	-10.7	-3.39	-7.5	-0.05	-0.76	-0.62	-0.16
Price/Free Cash Flow Average	- -	- -	-4.63	-115.66	-141.53	-55.53	-181.7	-126.59	-19.61	-11.7	-13.01	-6.05	-99.57	-1.58	-3.19
Price/Free Cash Flow High	- -	- -	-6.74	-856.46	-291.78	-154.75	-1,136.98	-348.65	-62.15	-30.41	-33.35	-15.74	-376.45	-6.06	-10.53
Price/Free Cash Flow Low	- -	- -	-3.74	-18.35	-66.08	-18.05	-5.98	-69.96	-11.51	-3.49	-7.5	-0.05	-0.76	-0.62	-0.16
EV/Sales Average	- -	- -	- -	- -	- -	61.38	24,951.31	13,601.07	5,792.21	4,322.91	- -	403.09	72.95	12.79	- -
EV/Sales High	- -	- -	- -	- -	- -	171.38	159,242.89	37,715.03	18,419.19	11,403.96	- -	961.76	267.57	21.4	- -
EV/Sales Low	- -	- -	- -	- -	- -	19.84	248.75	7,452.21	3,388.94	1,212.47	- -	57.93	3.49	10.95	- -
EV/EBITDA Average	-5.12	-6.48	-0.92	-87.66	-46.87	-24.74	-76.79	-35.1	-18.3	-10.94	-14.41	-4.38	-38.89	-3.26	-16.66
EV/EBITDA High	-16.24	-16.35	-1.91	-652.08	-96.67	-69.08	-490.09	-97.33	-58.21	-28.86	-37.27	-10.46	-142.66	-5.45	-44.93
EV/EBITDA Low	-1.62	-4.34	-0.51	-13.52	-21.86	-8	-0.77	-19.23	-10.71	-3.07	-8.22	-0.63	-1.86	-2.79	-4.96
EV/EBIT Average	-5.12	-6.48	-0.92	-87.63	-46.75	-24.6	-76.5	-34.29	-17.26	-10.17	-13.18	-4.09	-32.12	-2.85	-16.66
EV/EBIT High	-16.24	-16.35	-1.91	-651.82	-96.44	-68.69	-488.23	-95.07	-54.88	-26.82	-34.1	-9.75	-117.83	-4.77	-44.93
EV/EBIT Low	-1.62	-4.34	-0.51	-13.52	-21.8	-7.95	-0.76	-18.79	-10.1	-2.85	-7.52	-0.59	-1.54	-2.44	-4.96
Last Price	29.4	15	9	59.99	21.6	5.98	122.4	109.2	31.2	22.92	20.4	3.4	0.02	0.01	- -
High Price	180	29.4	16.2	168	61.2	21.6	912	358.8	162	73.2	72	21.6	4.8	0.05	0.02
Enterprise Value Average	1	- -	- -	19	25	7	142	131	57	31	34	12	30	2	5
Enterprise Value High	2	- -	- -	140	52	19	905	362	181	82	89	29	110	3	12
Enterprise Value Low	- -	- -	- -	3	12	2	1	72	33	9	20	2	1	1	1

Shares Outstanding	- -	- -	- -	1	1	1	1	1	1	1	1	1	23	31	554
Diluted Weighted Avg Shares	- -	- -	- -	1	1	1	1	1	1	1	1	1	9	30	91
Basic Weighted Avg Shares	- -	- -	- -	1	1	1	1	1	1	1	1	1	9	30	91
Revenue per Share	- -	- -	- -	- -	- -	0.13	0.01	0.01	0.01	0.01	- -	0.02	0.05	- -	- -
EBITDA per Share	-11.09	-1.8	-5.11	-0.26	-0.64	-0.32	-2.01	-3.71	-2.82	-2.52	-2.06	-2.25	-0.09	-0.02	- -
Operating Income per Share	-11.09	-1.8	-5.11	-0.26	-0.64	-0.33	-2.02	-3.8	-2.99	-2.71	-2.25	-2.42	-0.11	-0.02	- -
Basic EPS, GAAP	-9.47	-0.15	-4.98	-0.32	-0.65	-0.36	-2.1	-3.76	1.03	-6.66	-2.77	-3.59	-0.42	-0.02	- -
Basic EPS from Cont Ops	-9.47	-0.15	-4.98	-0.26	-0.65	-0.36	-2.1	-3.76	1.03	-6.66	-2.77	-3.59	-0.42	-0.02	- -
Diluted EPS, GAAP	-9.47	-0.15	-4.98	-0.32	-0.65	-0.36	-2.1	-3.76	1.03	-6.66	-2.77	-3.59	-0.42	-0.02	- -
Diluted EPS from Cont Ops	-9.47	-0.15	-4.98	-0.26	-0.65	-0.36	-2.1	-3.76	1.03	-6.66	-2.77	-3.59	-0.42	-0.02	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	-2.4	-0.23	-0.21	-0.14	-0.94	-1.97	-2.8	-2.47	-2.16	-1.37	-0.01	-0.01	- -
Free Cash Flow per Basic Share	- -	- -	-2.4	-0.27	-0.22	-0.14	-1.08	-2.91	-3	-2.54	-2.16	-1.37	-0.01	-0.01	- -
Cash & Equivalents per Share	- -	- -	6.42	0.12	0.03	0.02	3.38	1.38	3.14	0.69	1.12	0.09	0.01	- -	- -
Book Value per Share	-4.18	-4.32	-9.3	0.05	-0.37	-0.52	2.95	2.61	13.16	1.57	1.46	-1.3	-0.09	-0.08	- -
Tangible Book Value per Share	-4.18	-4.32	-9.3	0.05	-0.37	-0.52	2.95	2.61	9.71	1.57	1.46	-1.3	-0.09	-0.08	- -

CNBX Pharmaceuticals Inc.